Beyond Air Inc. fell 13.22% in after-hours trading following its Q2 2026 earnings report, which highlighted revenue of $1.8 million (128% YoY growth but below the $2.54 million estimate) and a wider-than-expected net loss of $1.25 per share. The report also disclosed supply chain delays for its second-generation LungFit PH system and flat sequential revenue growth. Management attributed the shortfall to hospital purchasing cycle variability and leadership transitions. Despite international expansion and cost reductions, the revenue miss, wider loss, and revised $8–$10 million guidance signaled investor concerns over execution risks and profitability. The stock’s sharp decline reflected disappointment over near-term operational challenges, overshadowing positive developments like a $12 million debt raise and reaffirmed analyst Buy ratings.
Comments
No comments yet